Bangladesh has rapidly emerged as a major pharmaceutical exporting nation, with demand for medicines rising sharply in recent years and the market projected to grow at a CAGR of over 12% by 2025. With generic drugs expected to surpass 85% of total market share, local companies are firmly positioned to dominate both domestic and international markets. This strength is underpinned by cost‑effective manufacturing, a skilled workforce, and strong government support through favorable policies and incentives. Bangladesh already exports to more than 150 countries, including highly regulated markets such as the United States and Europe, proving its global competitiveness. Combined with expanding API production, rising healthcare demand, and strategic integration into regional supply chains, Bangladesh offers unmatched opportunities for investors and partners seeking to tap into one of the fastest‑growing pharmaceutical hubs in Asia.